Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry

Overview of attention for article published in Acta Neuropathologica Communications, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

DIPG Can't Beat Me: The Western Pennsylvania Chapter of The Cure Starts Now, 31 Jul 2018

We are so very proud to announce Dr. Carl Koschman's paper: Medulloblastoma therapy generates risk of a poorly-prognostic H3…

DIPG DMG Registry, 31 Jul 2018

We are so very proud to announce Dr. Carl Koschman's paper: Medulloblastoma therapy generates risk of a poorly-prognostic H3…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.